Regulatory Story
Go to market news section View chart   Print
Company HydroDec Group plc
TIDM HYR
Headline

US Strategic Relationship

Released 07:00 30-Nov-2012
Number 3840S07

RNS Number : 3840S
HydroDec Group plc
30 November 2012
 



30 November 2012

 

US Strategic Relationship

 

Hydrodec Group plc ("Hydrodec"), the cleantech industrial oil re-refining group (AIM: HYR), announces that it has signed a non-binding heads of terms to establish a potential Joint Venture with an industry participant in North America.

Under the terms of the proposed arrangement:

(1)     The industry participant would provide a committed volume of feedstock sufficient to expand production capacity by up to a further six processing trains - Hydrodec's Canton plant currently has four trains - increasing total capacity in North America up to c. 65 million litres from 27 million litres currently. 

(2)     Hydrodec will licence its technology to the Joint Venture to manufacture oil in North America in return for a five per cent royalty on the revenues generated by the business.

(3)     The industry participant would initially acquire a 25 per cent interest in Hydrodec's US business and (subject to the build out of further processing trains) would acquire up to 49.9 per cent in the Joint Venture. The industry participant will pay a price 5 times the EBITDA for the US business for the period ended 31 December 2012 subject to an earn-out equivalent to 6.5 times by which the EBITDA for the year ended 31 December 2013 exceeds that of 2012.

Completion of the proposed transaction is subject to: (i) entering into definitive legally binding agreements; and (ii) obtaining all necessary approvals. There can be no assurance that the transaction will be concluded.

Ian Smale, Chief Executive of Hydrodec, commented: "This is the first step in what would be a significant strategic relationship for Hydrodec.  The potential to dramatically increase our capacity and have access to long-term, stable supplies of feedstock will enable us to scale up our North American operations and help Hydrodec take advantage of the strong market demand for our products."

For further information please contact:

Hydrodec Group plc

020 7907 9220

Ian Smale, Chief Executive Officer

Chris Ellis, Chief Financial Officer


Mike Preen, Head of Corporate and Legal Affairs


Numis Securities Limited

(Nominated adviser/joint broker)

020 7260 1000

Nominated Adviser: Hugh Jonathan

Corporate Broker: David Poutney, Alex Ham

 

Cenkos Securities plc (Joint broker)

Corporate Finance: Adrian Hargrave

Sales: Christian Hobart

 

 

 

020 7397 8900

Luther Pendragon (PR adviser to Hydrodec)

020 7618 9100       

Neil Thapar, Alexis Gore

 


Notes to Editors:

Hydrodec's technology is a proven highly efficient oil re-refining and chemical process which is being initially targeted at the multi-billion US$ market for transformer oil used by the world's electricity industry. The Group takes spent oil, including polychlorinated biphenyl ("PCB") contaminated oil, as the primary feedstock, which is then processed at its two plants enabling 99 per cent or greater recovery of oil for reuse while also eliminating PCBs, a toxic additive banned under international regulations, without environmentally harmful emissions.

Hydrodec's plants are located at Canton, Ohio, US and Young, New South Wales, Australia. The Group's shares are listed on the AIM Market of the London Stock Exchange. For further information, please visit www.hydrodec.com.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
JVEFEAEDUFESESF
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


US Strategic Relationship - RNS